Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
18
NCT02748135
A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma
Phase: Phase 1
Role: Lead Sponsor
Start: May 31, 2016
Completion: Oct 6, 2020